本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

12.88
-0.1400-1.08%
成交量:6.47万
成交额:82.95万
市值:4.41亿
市盈率:-13.79
高:13.02
开:13.02
低:12.65
收:13.02
52周最高:16.76
52周最低:9.85
股本:3,425.49万
流通股本:1,792.50万
量比:0.29
换手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
净资产收益率:-29.58%
总资产收益率:-19.93%
市净率:2.41
市盈率(LYR):-12.30

数据加载中...

2021/04/28

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/27

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/24

重要事件披露

8-K - Current report
2021/02/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/19

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/15

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/03

重要事件披露

8-K - Current report
2020/10/27

重要事件披露

8-K - Current report
2020/10/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals